U.S. Markets closed

Qiwi plc (QIWI) in Focus: Stock Moves 6.9% Higher

Zacks Equity Research

Qiwi plc QIWI was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading within a volatile range of $22.51 –$25.25 in the past one-month time frame, showed a sharp increase yesterday to $24.00.

The company has seen no estimate revisions over the past one month, and the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

PayPoint currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

QIWI PLC Price and Consensus

QIWI PLC Price and Consensus | QIWI PLC Quote

Another stock worth considering in the  Financial Transaction Services industry is PayPoint plc PYPTF which carries a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Is QIWI going up? Or down? Predict to see what others think:Up or Down

More Stock News: 8 Companies Verge on Apple-Like Run

Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.

A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
QIWI PLC (QIWI) : Free Stock Analysis Report
 
PAYPOINT PLC (PYPTF) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research